Biotech

All Articles

OS Treatments refiles $6M IPO to cash HER2 drug, preclinical ADCs

.OS Therapies are going to list on the NYSE American supply exchange today by means of a $6.4 thousa...

ALX's waning CD47 reaction fee sends out sell spiraling down

.ALX Oncology's stage 2 stomach cancer action cost has actually damaged. After seeing its own CD47 b...

Ionis axes eye ailment coming from aim ats of Roche-partnered possibility after records let down

.An Additional of Ionis Pharmaceuticals' essential midphase readouts has actually fallen short of de...

Biogen's CEO stated no dangerous handle 2023. He prepares to become daring

.While Biogen's pharma peers are actually looking for late-stage assets with little bit of danger, c...

Instil refills pipe in $2B biobucks manage ImmunOnco

.Instil Biography has actually been a biotech seeking a pipe after it scrapped its own lead assets o...

Biogen ignores Denali Alzheimer's collab

.Biogen has returned legal rights to an early Alzheimer's illness course to Denali Therapies, going ...

Takeda faucets brand-new head people oncology business-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of notable leadership hirings, firings as we...

Vertex, hammered through AATD once again, drops 2 resources on dispose of pile

.Vertex's try to deal with an uncommon hereditary ailment has actually attacked another setback. The...

Vir increases 3 T-cell engagers coming from Sanofi, gives up 25% of personnel

.Vir Biotechnology's second-quarter incomes document wasn't except huge information. The provider we...

Galapagos stops CAR-T cell therapy hearing over Parkinsonism scenario

.Galapagos has actually stopped application in a trial of a BCMA-directed CAR-T cell treatment, push...